This report aims to provide a comprehensive presentation of the global market for Adult Chronic Hepatitis B Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult Chronic Hepatitis B Treatment. This report contains market size and forecasts of Adult Chronic Hepatitis B Treatment in global, including the following market information:
Global Adult Chronic Hepatitis B Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Adult Chronic Hepatitis B Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Interferon Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adult Chronic Hepatitis B Treatment include Novartis, ViiV Healthcare, Bristol-Myers Squibb, Gilead Sciences, Accord Healthcare, Teva Pharmaceuticals, Apotex Corp, CTTQ and Arbutus Biopharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adult Chronic Hepatitis B Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adult Chronic Hepatitis B Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Adult Chronic Hepatitis B Treatment Market Segment Percentages, by Type, 2022 (%)
Interferon
Antiviral Drugs
Global Adult Chronic Hepatitis B Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Adult Chronic Hepatitis B Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Homecare
Clinics
Others
Global Adult Chronic Hepatitis B Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Adult Chronic Hepatitis B Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adult Chronic Hepatitis B Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adult Chronic Hepatitis B Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
ViiV Healthcare
Bristol-Myers Squibb
Gilead Sciences
Accord Healthcare
Teva Pharmaceuticals
Apotex Corp
CTTQ
Arbutus Biopharma
Lupin Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adult Chronic Hepatitis B Treatment, market overview.
Chapter 2: Global Adult Chronic Hepatitis B Treatment market size in revenue.
Chapter 3: Detailed analysis of Adult Chronic Hepatitis B Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adult Chronic Hepatitis B Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adult Chronic Hepatitis B Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adult Chronic Hepatitis B Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adult Chronic Hepatitis B Treatment Overall Market Size
2.1 Global Adult Chronic Hepatitis B Treatment Market Size: 2022 VS 2029
2.2 Global Adult Chronic Hepatitis B Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adult Chronic Hepatitis B Treatment Players in Global Market
3.2 Top Global Adult Chronic Hepatitis B Treatment Companies Ranked by Revenue
3.3 Global Adult Chronic Hepatitis B Treatment Revenue by Companies
3.4 Top 3 and Top 5 Adult Chronic Hepatitis B Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adult Chronic Hepatitis B Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adult Chronic Hepatitis B Treatment Players in Global Market
3.6.1 List of Global Tier 1 Adult Chronic Hepatitis B Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Adult Chronic Hepatitis B Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Adult Chronic Hepatitis B Treatment Market Size Markets, 2022 & 2029
4.1.2 Interferon
4.1.3 Antiviral Drugs
4.2 By Type - Global Adult Chronic Hepatitis B Treatment Revenue & Forecasts
4.2.1 By Type - Global Adult Chronic Hepatitis B Treatment Revenue, 2018-2023
4.2.2 By Type - Global Adult Chronic Hepatitis B Treatment Revenue, 2024-2029
4.2.3 By Type - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adult Chronic Hepatitis B Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Clinics
5.1.5 Others
5.2 By Application - Global Adult Chronic Hepatitis B Treatment Revenue & Forecasts
5.2.1 By Application - Global Adult Chronic Hepatitis B Treatment Revenue, 2018-2023
5.2.2 By Application - Global Adult Chronic Hepatitis B Treatment Revenue, 2024-2029
5.2.3 By Application - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Adult Chronic Hepatitis B Treatment Market Size, 2022 & 2029
6.2 By Region - Global Adult Chronic Hepatitis B Treatment Revenue & Forecasts
6.2.1 By Region - Global Adult Chronic Hepatitis B Treatment Revenue, 2018-2023
6.2.2 By Region - Global Adult Chronic Hepatitis B Treatment Revenue, 2024-2029
6.2.3 By Region - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Adult Chronic Hepatitis B Treatment Revenue, 2018-2029
6.3.2 US Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.3.3 Canada Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.3.4 Mexico Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Adult Chronic Hepatitis B Treatment Revenue, 2018-2029
6.4.2 Germany Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.3 France Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.4 U.K. Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.5 Italy Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.6 Russia Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.8 Benelux Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Adult Chronic Hepatitis B Treatment Revenue, 2018-2029
6.5.2 China Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.3 Japan Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.4 South Korea Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.6 India Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Adult Chronic Hepatitis B Treatment Revenue, 2018-2029
6.6.2 Brazil Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.6.3 Argentina Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adult Chronic Hepatitis B Treatment Revenue, 2018-2029
6.7.2 Turkey Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7.3 Israel Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7.5 UAE Adult Chronic Hepatitis B Treatment Market Size, 2018-2029
7 Adult Chronic Hepatitis B Treatment Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Adult Chronic Hepatitis B Treatment Major Product Offerings
7.1.4 Novartis Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 ViiV Healthcare
7.2.1 ViiV Healthcare Company Summary
7.2.2 ViiV Healthcare Business Overview
7.2.3 ViiV Healthcare Adult Chronic Hepatitis B Treatment Major Product Offerings
7.2.4 ViiV Healthcare Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.2.5 ViiV Healthcare Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Gilead Sciences
7.4.1 Gilead Sciences Company Summary
7.4.2 Gilead Sciences Business Overview
7.4.3 Gilead Sciences Adult Chronic Hepatitis B Treatment Major Product Offerings
7.4.4 Gilead Sciences Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.4.5 Gilead Sciences Key News & Latest Developments
7.5 Accord Healthcare
7.5.1 Accord Healthcare Company Summary
7.5.2 Accord Healthcare Business Overview
7.5.3 Accord Healthcare Adult Chronic Hepatitis B Treatment Major Product Offerings
7.5.4 Accord Healthcare Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.5.5 Accord Healthcare Key News & Latest Developments
7.6 Teva Pharmaceuticals
7.6.1 Teva Pharmaceuticals Company Summary
7.6.2 Teva Pharmaceuticals Business Overview
7.6.3 Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Major Product Offerings
7.6.4 Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.6.5 Teva Pharmaceuticals Key News & Latest Developments
7.7 Apotex Corp
7.7.1 Apotex Corp Company Summary
7.7.2 Apotex Corp Business Overview
7.7.3 Apotex Corp Adult Chronic Hepatitis B Treatment Major Product Offerings
7.7.4 Apotex Corp Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.7.5 Apotex Corp Key News & Latest Developments
7.8 CTTQ
7.8.1 CTTQ Company Summary
7.8.2 CTTQ Business Overview
7.8.3 CTTQ Adult Chronic Hepatitis B Treatment Major Product Offerings
7.8.4 CTTQ Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.8.5 CTTQ Key News & Latest Developments
7.9 Arbutus Biopharma
7.9.1 Arbutus Biopharma Company Summary
7.9.2 Arbutus Biopharma Business Overview
7.9.3 Arbutus Biopharma Adult Chronic Hepatitis B Treatment Major Product Offerings
7.9.4 Arbutus Biopharma Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.9.5 Arbutus Biopharma Key News & Latest Developments
7.10 Lupin Pharmaceuticals
7.10.1 Lupin Pharmaceuticals Company Summary
7.10.2 Lupin Pharmaceuticals Business Overview
7.10.3 Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Major Product Offerings
7.10.4 Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.10.5 Lupin Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Adult Chronic Hepatitis B Treatment Market Opportunities & Trends in Global Market
Table 2. Adult Chronic Hepatitis B Treatment Market Drivers in Global Market
Table 3. Adult Chronic Hepatitis B Treatment Market Restraints in Global Market
Table 4. Key Players of Adult Chronic Hepatitis B Treatment in Global Market
Table 5. Top Adult Chronic Hepatitis B Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Adult Chronic Hepatitis B Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Adult Chronic Hepatitis B Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Adult Chronic Hepatitis B Treatment Product Type
Table 9. List of Global Tier 1 Adult Chronic Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adult Chronic Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Adult Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Adult Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Adult Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Adult Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Adult Chronic Hepatitis B Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Adult Chronic Hepatitis B Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Adult Chronic Hepatitis B Treatment Product Offerings
Table 32. Novartis Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. ViiV Healthcare Company Summary
Table 35. ViiV Healthcare Adult Chronic Hepatitis B Treatment Product Offerings
Table 36. ViiV Healthcare Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. ViiV Healthcare Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Product Offerings
Table 40. Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Gilead Sciences Company Summary
Table 43. Gilead Sciences Adult Chronic Hepatitis B Treatment Product Offerings
Table 44. Gilead Sciences Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Gilead Sciences Key News & Latest Developments
Table 46. Accord Healthcare Company Summary
Table 47. Accord Healthcare Adult Chronic Hepatitis B Treatment Product Offerings
Table 48. Accord Healthcare Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Accord Healthcare Key News & Latest Developments
Table 50. Teva Pharmaceuticals Company Summary
Table 51. Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Product Offerings
Table 52. Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Pharmaceuticals Key News & Latest Developments
Table 54. Apotex Corp Company Summary
Table 55. Apotex Corp Adult Chronic Hepatitis B Treatment Product Offerings
Table 56. Apotex Corp Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Apotex Corp Key News & Latest Developments
Table 58. CTTQ Company Summary
Table 59. CTTQ Adult Chronic Hepatitis B Treatment Product Offerings
Table 60. CTTQ Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. CTTQ Key News & Latest Developments
Table 62. Arbutus Biopharma Company Summary
Table 63. Arbutus Biopharma Adult Chronic Hepatitis B Treatment Product Offerings
Table 64. Arbutus Biopharma Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Arbutus Biopharma Key News & Latest Developments
Table 66. Lupin Pharmaceuticals Company Summary
Table 67. Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Product Offerings
Table 68. Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Lupin Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Adult Chronic Hepatitis B Treatment Segment by Type in 2022
Figure 2. Adult Chronic Hepatitis B Treatment Segment by Application in 2022
Figure 3. Global Adult Chronic Hepatitis B Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adult Chronic Hepatitis B Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Adult Chronic Hepatitis B Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adult Chronic Hepatitis B Treatment Revenue in 2022
Figure 8. By Type - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 16. US Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 28. China Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Adult Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Adult Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. ViiV Healthcare Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gilead Sciences Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Accord Healthcare Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Apotex Corp Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. CTTQ Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Arbutus Biopharma Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
